Outcome Measures Study
We are pleased to report on the results from the preliminary data collected in a study looking
at outcome measures from 205 clients who attended a Lightning Process seminar. The
study, which has been done using the RAND SF-36, is a pilot study that was designed to
provide some preliminary outcome measures which can be used to add weight to future
grant and funding applications for larger-scale Randomised Controlled Trials (RCT).
The information given below reflect the results to date after clients completed RAND SF-36
questionnaires before they attended the course, at 6 weeks after attending the course and at
3 months after attending the course.
The study is not complete as yet, as further data is being collected at 6 months and 12
months after attending the course.
The data is part of an outcome measure study rather than a RCT (or compared against any
control group) and can therefore only reflect a cross-sectional follow-up tracing
improvements with those participants who attended the LP course. All client diagnoses used
in this data collection are provided by the clients - who also provided the names of the
medical staff who gave them the diagnosis.
The data has been independently analysed by a UK Research Establishment.
!"#$%&"&#'()*+,--.''
(),/"0"&1)2'34567'89%+*0,-':1%1'
!"#$%&'&()
!"#"$%"&'("$)*+")',-./,)'*)012'30("'45'3")%012'67'8"9"8):';+"<%")%='>'?""@)='7'(41%A)B'?"+"'C4(#*%"&'%4'$1$8D)"'
%A"'E'&0("1)041)'45'%A"'!,-F'GH<7>I'J"$8%A'CA$12"='#AD)0C$8'5*1C%041012='+48"'80(0%$%041)'&*"'%4'#AD)0C$8'A"$8%A='+48"'
80(0%$%041)' &*"' %4' "(4%041$8' #+4K8"()=' "1"+2DL5$%02*"=' "(4%041$8' ?"88<K"012=' )4C0$8' 5*1C%041012=' #$01' $1&' 2"1"+$8'
A"$8%AM' N+""1A4*)"<N"0))"+' #4)%<A4C' C4++"C%041)' $1&' O415"++410' #4)%<A4C' C4(#$+0)41)' ?"+"' $##80"&M' F")C+0#%09"'
G%$%0)%0C)'$+"'+"#4+%"&'$)'P"$1)'$1&'G%$1&$+&'F"90$%041)M'P0))012'&$%$'?$)'"QC8*&"&'5+4('%A"'$1$8D)0)M'
*#+,'-'.#",&()
,'%4%$8'45'RST'#$+%0C0#$1%)'A$&'C4(#8"%"&'%A"'U02A%1012';+4C"))'3+$01012';+42+$(("M'P"$1'$2"'45'#$+%0C0#$1%)'$%'
%0("'45'"1%+D'%4'%A"'#+42+$(("'?$)'7VMW'D"$+)'45'$2"'6GFXYTM>'D"$+)BM'3?"1%D'#"+C"1%'45'#$+%0C0#$1%)'?"+"'($8"'
6-XWYB' $1&' ZS[' ?"+"' 5"($8"' 6-XY>W:' )""' H02*+"' YBM' ;+0($+D' )"85<+"#4+%"&' &0$214)")' $1&' +"$)41)' 54+' #+42+$(("'
$%%"1&$1C"'?"+"'#+"&4(01$1%8D'54+'5$%02*"<+"8$%"&')D1&+4(")')*CA'$)'PD$820C'\1C"#A$84(D"80%0)'4+']A+410C'H$%02*"'
GD1&+4("' 6>WMW[=' -XY7RBM' ,1Q0"%DLF"#+"))041' &0)4+&"+)' ?"+"' $8)4' C4((41=' ?0%A' YVMY[' 45' #$+%0C0#$1%)' 6-X7TB'
+"#4+%012' ,1Q0"%DLF"#+"))041M' RME[' 45' #$+%0C0#$1%)' +"#4+%"&' )*55"+012' 5+4(' P*8%0#8"' GC8"+4)0)' 6-X>B' $1&' $' 5*+%A"+'
RME['45'#$+%0C0#$1%)'+"#4+%"&'%A"'&0$214)0)'45'H0K+4(D$820$'6-X>BM'H*+%A"+'+"$)41)'54+'$%%"1&$1C"'?"+"'209"1')*CA'$)'
84?')"85<")%""('6RMW[='-XTB='CA+410C'#$01'6YMT[='-X7B='$&&0C%09"'&0)4+&"+)'6Y[='-XRB='.K)"))09"']4(#*8)09"'F0)4+&"+'
6SMT[='-XYB'4+'4%A"+L*1@14?1'&0$214)")'6VM7[='-XYTBM'F0$214)")'$+"'209"1'01'H02*+"'RM''
'
!"#$%&'()'-4M'45'#$+%0C0#$1%)'$CC4+&012'%4'2"1&"+M'
'
!
!"#$%&'()!"#$%&'#()'*#+!+,-./)0#0!-/+!'#-0)/0!%)'!1,.2*/,/.!3')4#00!*'-,/,/.!(').'-55#!-**#/+-/4#
'#()'*#+!+,-./)0#0!-/+!'#-0)/0!%)'!1,.2*/,/.!3')4#00!*'-,/,/.!(').'-55#!-**#/+-/4#
'#()'*#+!+,-./)0#0!-/+!'#-0)/0!%)'!1,.2*/,/.!3')4#00!*'-,/,/.!(').'-55#!-**#/+-/4#!
!
!"#$%&#'
6#(#-*#+! 7#-08'#0! 9:;<90! 02)=#+! -! 0,./,%,4-/*! +,%%#'#/4#! ,/! -$$! 08>&04-$#0!
08> 04-$#0! )%! *2#! 69:W! "V&IT!
"V
-4')00! ?,5#! )%!
?#0*,/.@! A#-$*2!42-/.#! B!BCDEFGHCFIJCKD!
BCDEFGHCFIJCKD!*PJFFFCGQ! 32L0,4-$! V8/4*,)/,/.! B!BMD!CNTGHKMJNOD!
BMD!CNTGHKMJNOD!*PJFFFCGQ! 6)$#! $,5,*-*,)/0!
+8#! *)! 32L0,4-$! A#-$*2! B!BMD!
BMD! CNNGHONJFCD! *PJFFFCGQ!
PJFFFCGQ! 6)$#! $,5,*-*,)/0! +8#! *)! #5)*,)/-$! (')>$#50! B!BMD!
B
CNTGHIMJTMD!
*PJFFFCGQ! R/#'.LS%-*,.8#! B!BMD!
BMD! CIMGHMIJEED! *PJFFFCGQ! R5)*,)/-$! =#$$&>#,/.! B!BMD!D! CNNGHCIJMKD! *PJFFFCGQ! ")4,-$!
%8/4*,)/,/.! B!BMD! CMMGHTIJUND! *PJFFFCGQ!
PJFFFCGQ! 3-,/! B!BMD!
B
CNUGHIKJNCD! *PJFFFCGQ!
PJFFFCGQ! -/+! \#/#'-$! A#-$*2! B!BMD!
B
CMUGHNCJEOD!
*PJFFFCGJ!?2,0!,/+,4-*#0!*2#!1,.2*/,/.!3')4#00!+)#0!,5(-4*!8()/!-$$!+,5#/0,)/0!)%!2#-$*2!*#0*#+!>L!*2#!"V
PJFFFCGJ!?2,0!,/+,4-*#0!*2#!1,.2*/,/.!3')4#00!+)#0!,5(-4*!8()/!-$$!+,5#/0,)/0!)%!2#-$*2!*#0*#+!>L!*2#!"V
PJFFFCGJ!?2,0!,/+,4-*#0!*2#!1,.2*/,/.!3')4#00!+)#0!,5(-4*!8()/!-$$!+,5#/0,)/0!)%!2#-$*2!*#0*#+!>L!*2#!"V&ITJ!
9$$! 08>&04-$#0! )%! *2#! 69:W! "V&IT!
IT! 02)=#+! 0,./,%,4-/*! ,5(')X#5#/*0! -4')00! ?,5#! )%! ?#0*,/.D! =,*2! 2#-$*2! 0*-*80!
,5(')X,/.!%')5!('#&1,.2*/,/.!3')4#00!*)!*2#!T!=##Y!%)$$)=
1,.2*/,/.!3')4#00!*)!*2#!T!=##Y!%)$$)=&8(!B*PJFFFCGJ!]5(')X#5#/*0!(#'0,0*#+!-*!I!5)/*20!%)'!-$$!
PJFFFCGJ!]5(')X#5#/*0!(#'0,0*#+!-*!I!5)/*20!%)'!-$$!
+,5#/0,)/0! B*PJFFFCG!
JFFFCG! #Z4#(*! ,/! *2#! *=)! #5)*,)/&'#$-*#+!
#5)*,)/ '#$-*#+! +,5#/0,)/0@! 6)$#! $,5,*-*,)/0! +8#! *)! #5)*,)/-$! (')>$#50!
-/+!R5)*,)/-$!=#$$&>#,/.J!!?2#!5-[)',*L!)%!*2#!08>
>#,/.J!!?2#!5-[)',*L!)%!*2#!08>&04-$#0!02)=#+!*2-*!2#-$*2!0*-*80!>#*=##/!T!=##Y0!-/+!I!5)/*20!
04-$#0!02)=#+!*2-*!2#-$*2!0*-*80!>#*=##/!T!=##Y0!-/+!I!5)/*20!
02)=#+! /)! %8'*2#'! 0,./,%,4-/*! ,5(')X#5#/*D! ,/+,4-*,/.!
,/+,4-*,/.! *2-*! ,5(')X#5#/*0! ($-*#-8#+! +8',/.! *2,0! (#',)+! -/+!
*2#'#%)'#! 2#-$*2! 0*-*80! -*! T! =##Y0! =-0! 5-,/*-,/#+! -*! I! 5)/*20J! A)=#X#'! %)'! *2#! #/#'.LS%-*,.8#! +,5#/0,)/D!
(-'*,4,(-/*0! 02)=#+! 4)/0#48*,X#! ,/4'#-0#0! ,/! *2#,'!#/#'.L!$#X#$0D!#Z2,>,*#+!*2')8.2!-!0,./,%,4-/*!
*2#,'!#/#'.L!$#X#$0D!#Z2,>,*#+!*2')8.2!-!0,./,%,
,/4'#-0#! >#*=##/!
('#&*#0*!-/+!T!=##Y0!B*PJFFFCG!-/+!-.-,/!%')5!T!=##Y0!*)!I!5)/*20!B
PJFFFCG!-/+!-.-,/!%')5!T!=##Y0!*)!I!5)/*20!B*PJFOQ!0##!V,.8'#!IGJ
PJFOQ!0##!V,.8'#!IGJ!
!"#$%&'(&!"#$%&'(&)"*#(+(&#(&$#*,-%*#./0#$+1"#*-,*(2"*345!*67089:*5;:*!+(+*,-%*9*+<=*>?*@-<(2#*&#*$.%%"<(1A*&<*$-11"$(&-<:*
!
!
!
6$78/0!907.:$!
"#$%&"!
3!
))*+,&
45!
-'*.+&
'!($$)*!
3!
45!
/'*0-&
-/*+,&
+!,-./0*!
3!
45!
/-*+.&
-/*+-&
'!,-./0*!
3!
&
45!
&
12!,-./0*!
3!
45!
&
&
!
!"
*111'&
"0;*<=78!>?.=/<-.<.:!
+2*/2&
)/*)+&
0,*-.&
)'*.)&
0+*,/&
'.*-,&
&
&
&
&
*111'&
"0;*<=78!@-8$!&<,</7/<-.*!
)'*+0&
-/*''&
2+*1/&
-0*'-&
2+*1/&
-.*2.&
&
&
&
&
*111'&
A,-/<-.78!@-8$!&<,</7/<-.*!
,.*')&
,,*)-&
0,*)-&
).*-'&
0'*.0&
-'*/.&
&
&
&
&
*111'&
A.$#:;B>7/<:?$!
--*+0&
)2*''&
2-*,-&
'0*//&
0,*/0&
20*21&
&
&
&
&
*111'&
A,-/<-.78!C$88%D$<.:!
2,*)/&
'-*..&
0,*..&
-2*+2&
/+*2)&
',*,'&
&
&
&
&
*111'&
4-=<78!>?.=/<-.<.:!
+'*+,&
).*'-&
0/*.,&
'2*+-&
0+*.2&
)1*0/&
&
&
&
&
*111'&
"7<.!
,'*,1&
-'*1/&
20*21&
-1*.,&
/,*11&
).*/0&
&
&
&
&
*111'&
E$.$#78!6$78/0!
,.*.)&
'0*20&
/'*'+&
'.*/)&
20*0+&
)1*).&
&
&
&
&
*111'&
!
!
?>>
J(./*-!K-.)L(
E>
!"#$%&'(%#%)*'+,-
D>
F-M+,3./!:0)3*,&),)L
C>
<>
F-M+,3./!5&/(!G,#,*.*,&)+
B>
N#&*,&)./!5&/(!
G,#,*.*,&)+
A>
;>
N)(%LMO:.*,L0(
@>
?>
N#&*,&)./!P(//21(,)L
>
F%(2GF
<!H((I+
;!#&)*-+
9&3,./!:0)3*,&),)L
./0"'12'."*%/34
!
!"#$%&'()!"#$%&'(#()*+!,)!-(./*-!+*.*0+!&)!*-(!+012+3./(+!&4!*-(!5678!9:2;<=!
We are pleased that this preliminary data supports the anecdotal evidence we receive on a
daily basis – ‘with the energy/fatigue dimension, participants showed consecutive increases
in their energy levels, exhibited through a significant increase between pre-test and 6 weeks
(p<.0001) and again from 6 weeks to 3 months (p<.05).’ The indications are that the LP is
making a significant positive impact, resulting in increased health status at 6 weeks,
persisting at 3 months, and demonstrating improvements in all areas that were covered by
the RAND SF36 questionnaire.
In two of the nine measured areas (the emotion-related dimensions) there was a significant
improvement on the baseline data, followed by a slight decrease, but with the scores at three
months still being significantly improved from the original baseline.
This interim data is useful information for the Lightning Process, supporting our findings to
date and highlighting areas to learn from. In light of this we are considering what measures
of additional support we can offer to clients, as required, to maintain and build on the
changes that are made following attendance of a Lightning Process seminar.
Full anonymised data is available on request.